Integra LifeSciences IART Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's operating cash flow?
- Integra LifeSciences (IART) reported operating cash flow of $9.8M in Q1 2026.
- How has Integra LifeSciences's operating cash flow changed year-over-year?
- Integra LifeSciences's operating cash flow increased by 187.1% year-over-year, from -$11.26M to $9.8M.
- What is the long-term trend for Integra LifeSciences's operating cash flow?
- Over 4 years (2021 to 2025), Integra LifeSciences's operating cash flow has grown at a -36.6% compound annual growth rate (CAGR), from $312.43M to $50.38M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.